CureMOG: A randomised double-blind placebo-controlled multicentre phase III clinical trial for the treatment of MOGAD

  • Ramanathan, Sudarshini (Primary Chief Investigator (PCI))
  • Butzkueven, Helmut (Chief Investigator (CI))
  • Brown, David Alexander (Chief Investigator (CI))
  • Van Der Walt, Anneke (Chief Investigator (CI))
  • Kalincik, Tomas (Chief Investigator (CI))
  • Miteff, Christina (Associate Investigator (AI))
  • Fraser, Clare (Associate Investigator (AI))
  • Klistorner, Alexandr (Associate Investigator (AI))
  • Hardy, Todd A. (Associate Investigator (AI))
  • Barnett, Michael Harry (Chief Investigator (CI))
  • Broadley, Simon (Chief Investigator (CI))
  • Spelman, Tim D. (Chief Investigator (CI))
  • Lindley, Richard Iain (Chief Investigator (CI))
  • Brilot-Turville, Fabienne (Chief Investigator (CI))
  • Dale, Russell Clive (Chief Investigator (CI))
  • Slee, Mark (Chief Investigator (CI))
  • Lewfelar, Julia (Chief Investigator (CI))
  • Reddel, Stephen William (Chief Investigator (CI))
  • Lechner-Scott, Jeanette (Chief Investigator (CI))
  • Monif, Mastura (Associate Investigator (AI))
  • George, Stacey (Associate Investigator (AI))

Project: Research

Project Details

StatusActive
Effective start/end date1/06/24 → 31/05/29